Back to results
US 7,405,285 B2Granted
Immunostimulatory oligonucleotide multimers
AssigneeIdera Pharmaceuticals, Inc.
InventorsSudhir Agrawal, Ekambar Kandimalla, Dong Yu
Life of this patent
Estimating the term…
Abstract
The invention provides an immunostimulatory nucleic acid. In certain embodiments according to this aspect of the invention, the sequence of the immunostimulatory oligonucleotide and/or immunomer is at least partially self-complementary.
Claims7
An immunostimulatory oligonucleotide having the structure 5′-TCG1AACG1TTCG1-Y-GACAG1CTGTCT-5′;
- wherein Y is a C3-linker, and G1 is 2′-deoxy-7-deazaguanosine.
A method for generating an immune response in a vertebrate, the method comprising administering to the vertebrate an immunostimulatory oligonucleotide having the structure 5′-TCG1AACG1TTCG1-Y-GACAG1CTGTCT-5′;
- wherein Y is a C3-linker, and G1 is 2′-deoxy-7-deazaguanosine.
Dependencies are inferred from the claim text.